Munafa Stock Market Course + Intraday & FNO calls 
Ascendis Pharma (ASND) Technical (Analysis) Reports Ascendis Pharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Ascendis Pharma (ASND)
Technical Analysis Report for NASDAQ stock ASND Ascendis Pharma. Dated: 04 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ASND Ascendis Pharma then click here. or read Experts views on Ascendis Pharma or Forecast & share price targets of Ascendis Pharma
Ascendis Pharma Opened at 221.00 and Closed at: 228.71, which is 3.4% of previous session's close. It moved within a range of 221.00 and 228.99
The session was a Bullish session with an average volume of 275600, which is -66.51% of previous session's volumes.
- There is some positive change in the short term trend, but its too soon to jump onto conclusions.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 4 days back on short term averages
A Dead cross was found 2 days back on mid term averages
Support for tomorrow is 224.86 and resistance for tomorrow is 232.85
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 223.48, 218.24 resistance for tomorrow's hourly charts is 231.47, 234.22
10 Day SMA for Ascendis Pharma (ASND) is 227.37 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Ascendis Pharma (ASND) is 234.06 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Ascendis Pharma (ASND) is 231.17 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 223.6 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Ascendis Pharma is 210.51 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Ascendis Pharma is at 234.06 and 200 DMA is at 210.51, while 50 DMA and 100 DMA are at 231.17 and 223.6 respectively
Ascendis Pharma (ASND) moving average of 20 SMA is at 234.06 and 20 EMA is at 230.09
| Date | Closing Price | 20 SMA | 20 EMA |
| 04 Mon May | 228.71 | 234.06 | 230.09 |
| 01 Fri May | 220.93 | 233.96 | 230.24 |
| 30 Thu Apr | 229.38 | 234.38 | 231.22 |
| 29 Wed Apr | 220.28 | 234.32 | 231.41 |
| 28 Tue Apr | 222.08 | 234.74 | 232.58 |
| 27 Mon Apr | 226.66 | 234.56 | 233.69 |
Ascendis Pharma (ASND) moving average of 50 SMA is at 231.17 and 50 EMA is at 229.08
| Date | Closing Price | 50 SMA | 50 EMA |
| 04 Mon May | 228.71 | 231.17 | 229.08 |
| 01 Fri May | 220.93 | 231.2 | 229.1 |
| 30 Thu Apr | 229.38 | 231.32 | 229.43 |
| 29 Wed Apr | 220.28 | 231.2 | 229.43 |
| 28 Tue Apr | 222.08 | 231.12 | 229.8 |
| 27 Mon Apr | 226.66 | 231.01 | 230.12 |
Ascendis Pharma (ASND) moving average of 100 SMA is at 223.6 and 100 EMA is at 223.28
| Date | Closing Price | 100 SMA | 100 EMA |
| 04 Mon May | 228.71 | 223.6 | 223.28 |
| 01 Fri May | 220.93 | 223.38 | 223.17 |
| 30 Thu Apr | 229.38 | 223.23 | 223.22 |
| 29 Wed Apr | 220.28 | 223.02 | 223.1 |
| 28 Tue Apr | 222.08 | 222.82 | 223.16 |
| 27 Mon Apr | 226.66 | 222.62 | 223.18 |
Ascendis Pharma (ASND) moving average of 200 SMA is at 210.51 and 200 EMA is at 209.3
| Date | Closing Price | 200 SMA | 200 EMA |
| 04 Mon May | 228.71 | 210.51 | 209.3 |
| 01 Fri May | 220.93 | 210.25 | 209.1 |
| 30 Thu Apr | 229.38 | 210.03 | 208.98 |
| 29 Wed Apr | 220.28 | 209.75 | 208.77 |
| 28 Tue Apr | 222.08 | 209.53 | 208.65 |
| 27 Mon Apr | 226.66 | 209.29 | 208.51 |
Sol Gel has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Sol Gel, about 5.54% more returns!
Ascendis Pharma has performed better than Pro Dex in short term. Holding Ascendis Pharma could be a better choice for now!
Pacira Pharmaceuticals has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 5.86% more returns!
Nektar Therapeutics has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 10.24% more returns!
Ascendis Pharma has performed better than Moderna Inc in short term. Holding Ascendis Pharma could be a better choice for now!
Lipocine Inc has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Lipocine Inc, about 10.77% more returns!
Acadia Healthcare has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Acadia Healthcare, about 5.29% more returns!
Ascendis Pharma has performed better than Amgen Inc in short term. Holding Ascendis Pharma could be a better choice for now!
Anaptysbio Inc has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Anaptysbio Inc, about 8.58% more returns!
Ascendis Pharma has performed better than Ani Pharmaceuticals in short term. Holding Ascendis Pharma could be a better choice for now!
Benitec Biopharma has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Benitec Biopharma, about 7.91% more returns!
Corcept Therapeutics has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 19.92% more returns!
Crispr Therapeutics has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 4.08% more returns!
Dare Bioscience has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Dare Bioscience, about 71.98% more returns!
Ascendis Pharma has performed better than Fortress Biotech in short term. Holding Ascendis Pharma could be a better choice for now!
Healthcare Services has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Healthcare Services, about 8.44% more returns!
Helius Medical has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Helius Medical, about 14.3% more returns!
Healthways Inc has performed better than Ascendis Pharma in short term. You could have earned much better returns by investing in Healthways Inc, about 6.3% more returns!
Ascendis Pharma Technical analysis of indicators
Price action analysis of Ascendis Pharma (ASND) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Ascendis Pharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Ascendis Pharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Ascendis Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Ascendis Pharma in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Ascendis Pharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 226.09 and Ascendis Pharma ASND stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Ascendis Pharma ASND stock. Volume based technical analysis of Ascendis Pharma ASND stock is negative.
Ascendis Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ASND Ascendis Pharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ASND Experts View which covers a lot of information including buying and selling signals
ASND future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Ascendis Pharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Ascendis Pharma (ASND) Technical (Analysis) Reports Ascendis Pharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
